Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids

References

• Ahuja, N., Singh, A., & Singh, B. (2003). Rofecoxib: An update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. The Journal of Pharmacy and Pharmacology, 55(7), 859–894.
   PubMed Web of Science ®Google Scholar
• Andersohn, F., Schade, R., Suissa, S., & Garbe, E. (2006). Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: A nested case-control study. Stroke, 37(7), 1725–1730.
   PubMed Web of Science ®Google Scholar
• Attiq, A., Jalil, J., Husain, K., & Ahmad, W. (2018). Raging the war against inflammation with natural products. Frontiers in Pharmacology, 9, 976.
   PubMed Web of Science ®Google Scholar
• Bahmani, M., Sarrafchi, A., Shirzad, H., Asgari, S., & Rafieian-Kopaei, M. (2017). Cardiovascular toxicity of cyclooxygenase inhibitors and promising Natur a l Substitutes. Current Pharmaceutical Design, 23(6), 952–960.
   PubMed Web of Science ®Google Scholar
• Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the Rule of 5 and Drugability. Advanced Drug Delivery Reviews, 101, 89–98.
   PubMed Web of Science ®Google Scholar
• Blobaum, A. L., & Marnett, L. J. (2007). Structural and functional basis of cyclooxygenase inhibition. Journal of Medicinal Chemistry, 50(7), 1425–1441.
   PubMed Web of Science ®Google Scholar
• Chandel, P., Rawal, R. K., & Kau, R. (2018). Natural products and their derivatives as cyclooxygenase-2 inhibitors. Future Medicinal Chemistry, 10.
   PubMed Web of Science ®Google Scholar
• David, C. C., & Jacobs, D. J. (2013). Principal component analysis: A method for determining the essential dynamics of proteins. Methods in Molecular Biology, 193–226.
   Google Scholar
• Egan, W. J., Zlokarnik, G., & Grootenhuis, P. D. J. (2004). In silico prediction of drug safety: Despite progress there is abundant room for improvement. Drug Discovery Today: Technologies, 1(4), 381–387.
   PubMedGoogle Scholar
• Ekins, S., Nikolsky, Y., & Nikolskaya, T. (2005). Techniques: Application of systems biology to absorption, distribution, metabolism, excretion and toxicity. Trends in Pharmacological Sciences, 26(4), 202–209.
   PubMed Web of Science ®Google Scholar
• Furse, K. E., Pratt, D. A., Porter, N. A., & Lybrand, T. P. (2006). Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: Insights into equilibrium behavior. Biochemistry, 45(10), 3189–3205.
   PubMed Web of Science ®Google Scholar
• Gouda, A. M., Ali, H. I., Almalki, W. H., Azim, M. A., Abourehab, M. A. S., & Abdelazeem, A. H. (2016). Design, synthesis, and biological evaluation of some novel pyrrolizine derivatives as COX inhibitors with anti-inflammatory/analgesic activities and low ulcerogenic liability. Molecules, 21, 201.
   Web of Science ®Google Scholar
• Haider, S., Parkinson, G. N., & Neidle, S. (2008). Molecular dynamics and principal components analysis of human telomeric quadruplex multimers. Biophysical Journal, 95(1), 296–311.
   PubMed Web of Science ®Google Scholar
• Hilário, M. O. E., Terreri, M. T., & Len, C. A. (2006). Nonsteroidal anti-inflammatory drugs: Cyclooxygenase 2 inhibitors. Jornal de pediatria (Rio J), 82(8), 206–212.
   Google Scholar
• Howe, L. R. (2007). Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Research, 9(4), 210.
   PubMed Web of Science ®Google Scholar
• Imhoff, J. F. (2016). Natural Products from marine fungi - Still an underrepresented resource. Marine Drugs, 14(1), 19.
   PubMed Web of Science ®Google Scholar
• Jackson, H. Jr. St. Louis Post-Dispatch, Aspirin, the mighty drug. (2007). The source.
   Google Scholar
• Khan, M. F., Bari, M. A., Islam, M. K., Islam, M. S., Kayser, M. S., Nahar, N., Faruk, M. A., & Rashid, M. A. (2017). The natural anti-tubercular agents: In silico study of physicochemical, pharmacokinetic and toxicological properties. Journal of Applied Pharmaceutical Science, 7(05), 034–038.
   Google Scholar
• Kothekar, V., Sahi, S., Srinivasan, M., Mohan, A., & Mishra, J. (2001). Recognition of cyclooxygenase-2 (COX-2) active site by NSAIDs: A computer modelling study. Indian Journal of Biochemistry & Biophysics, 38(1–2), 56–63.
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A., Open Source Drug Discovery Consortium. (2014). Open Source Drug Discovery Consortium, Lynn A. g_mmpbsa–a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962.
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786.
   PubMed Web of Science ®Google Scholar
• Levita, J., Nawaw, A., Mutalib, A., & Ibrahim, S. (2009). Analyzing the interaction of andrographolide and neoandrographolide, diterpenoid compounds from Andrographis. ITB Journal of Science, 41 A(2), 110–119.
   Google Scholar
• Lin, Y., Li, H., Jiang, G., Zhou, S., Vrijmoed, L. L. P., & Jones, E. B. G. (2002). A novel y-lactone, eutypoid-A and other metabolites from marine fungus Eutypa sp.(#424) from the South China Sea. IJC-B, 41, 1542–1544.
   Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26.
   PubMed Web of Science ®Google Scholar
• Liu, Q., Lei, Z., Zhu, F., Ihsan, A., Wang, X., & Yuan, Z. (2017). A novel strategy to predict carcinogenicity of antiparasitics based on a combination of DNA lesions and bacterial mutagenicity tests. Frontiers in Public Health, 5.
   Web of Science ®Google Scholar
• Marnett, L. J., & Kalgutkar, A. S. (1998). Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents. Current Opinion in Chemical Biology, 2(4), 482–490.
   PubMed Web of Science ®Google Scholar
• Marnett, L. J., Rowlinson, S. W., Goodwin, D. C., Kalgutkar, A. S., & Lanzo, C. A. (1999). Arachidonic acid oxygenation by COX-1 and COX-2: Mechanisms of catalysis and inhibition. The Journal of Biological Chemistry, 274(33), 22903–22906.
   PubMed Web of Science ®Google Scholar
• Mazola, Y., Guirola, O., Palomares, S., Chinea, G., Menendez, C., Hernandez, L., & Musacchio, A. (2015). A comparative molecular dynamics study of thermophilic and mesophilic beta-fructosidase enzymes. Journal of Molecular Modeling, 21(9), 2772.
   Web of Science ®Google Scholar
• Mortelmans, K., & Zeiger, E. (2000). The Ames Salmonella/microsome mutagenicity assay. Mutation Research, 455(1–2), 29–60.
   PubMed Web of Science ®Google Scholar
• Perrone, M. G., Scilimati, A., Simone, A., & Vitale, P. (2010). Selective COX-1 inhibition: A therapeutic target to be reconsidered. Current Medicinal Chemistry, 17(32), 3769–3805.
   PubMed Web of Science ®Google Scholar
• Schneider, C., Boeglin, W. E., & Brash, A. R. (2003). Identification of two cyclooxygenase active site residues, leucine 384 and glycine 526, that control carbon ring cyclization in prostaglandin biosynthesis. Journal of Medicinal Chemistry, 279(6), 4404–4414.
   Google Scholar
• Schneider, C., Boeglin, W. E., Prusakiewicz, J. J., Rowlinson, S. W., Marnett, L. J., Samel, N., & Brash, A. R. (2001). Control of prostaglandin stereochemistry at the 15-carbon by cyclooxygenases-1 and -2: A critical role for serine 530 and valine 349. Journal of Biological Chemistry, 277(1), 478–485.
   PubMed Web of Science ®Google Scholar
• Schulz, D., Ohlendorf, B., Zinecker, H., Johann, R. S., & Imhoff, J. F. (2011). Eutypoids B-E produced by a Penicillium sp. strain from the North Sea. Journal of Natural Products, 74(1), 99–101.
   PubMed Web of Science ®Google Scholar
• Thuresson, E. D., Lakkides, K. M., Rieke, C. J., Sun, Y., Wingerd, B. A., Micielli, R., Mulichak, A. M., Malkowski, M. G., Garavito, R. M., & Smith, W. L. (2000). Prostaglandin endoperoxide H synthase-1: The functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid. The Journal of Biological Chemistry, 276(13), 10347–10357.
   PubMed Web of Science ®Google Scholar
• Vecchio, A. J., Orlando, B. J., Nandagiri, R., & Malkowski, M. G. (2012). Investigating substrate promiscuity in cyclooxygenase-2: The role of Arg-120 and residues lining the hydrophobic groove. The Journal of Biological Chemistry, 287(29), 24619–24630.
   PubMed Web of Science ®Google Scholar
• Wilson, P. B. (2015). Ginger (Zingiber officinale) as an analgesic and ergogenic aid in sport: A systemic review. Journal of Strength and Conditioning Research, 29(10), 2980–2995.
   PubMed Web of Science ®Google Scholar